PMGC Holdings ELAB
NASDAQ ELAB
$4.62 +0.00 (+0.00%)
As of: Sep 10, 2026 · 9:30 AM EDT

PMGC Holdings (ELAB) Research & Development (2022 - 2026)

PMGC Holdings' (ELAB) quarterly Research & Development came in at $310219.0 in Q2 2026, up 186.34% quarter-over-quarter from $108341.0 in Q1 2026.

Analysis

PMGC Holdings (ELAB) Research & Development (2022 - 2026) Analysis & Trends

PMGC Holdings has disclosed Research & Development across 5 years of filings, most recently posting $310219.0 for Q2 2026.

  • In Q2 2026, Research & Development changed N/A year-over-year to $310219.0; the TTM figure through Jun 2026 stood at $523525.0 (changed N/A YoY), while the FY2025 annual figure was $160376.0, changed N/A from the prior year.
  • Research & Development came in at $310219.0 for Q2 2026 at PMGC Holdings, up from $108341.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $89.3 million in Q3 2022 to a low of -$167.7 million in Q4 2022.
  • Average Research & Development over 5 years is -$5.8 million, with a median of $108341.0 recorded in 2026.
  • Year-over-year, Research & Development plunged 99.9% in 2023 and jumped 439.82% in 2024.
  • Over 5 years, Research & Development stood at -$167.7 million in 2022, then surged by 100.21% to $356522.0 in 2023, then plunged by 73.28% to $95260.0 in 2024, then plunged by 57.28% to $40692.0 in 2025, then surged by 662.36% to $310219.0 in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $310219.0 in Q2 2026, $108341.0 in Q1 2026, and $40692.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Amgen 209.88 Bn 195.89 Bn 7.24 Bn 1.87 Bn
2 Gilead Sciences 179.94 Bn 176.76 Bn 6.22 Bn 1.76 Bn
3 Vertex Pharmaceuticals 131.92 Bn 124.07 Bn 2.84 Bn 993.80 Mn
4 Regeneron Pharmaceuticals 81.96 Bn 73.96 Bn 3.93 Bn 1.63 Bn
5 Argenx Se 61.21 Bn 56.02 Bn 1.37 Bn -486.00 Mn
6 Moderna 53.53 Bn 48.39 Bn 52.00 Mn 651.00 Mn
7 Alnylam Pharmaceuticals 33.65 Bn 30.34 Bn 992.69 Mn 413.13 Mn
8 Biogen 31.83 Bn 30.55 Bn 1.96 Bn 529.60 Mn
9 Roivant Sciences 29.64 Bn 29.64 Bn 1.16 Mn 202.02 Mn
10 PMGC Holdings 2.25 Mn -16.54 Mn 385,691.00 310,219.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 310,219.00
Mar 31, 2026 108,341.00
Dec 31, 2025 40,692.00
Sep 30, 2025 64,273.00
Sep 30, 2024 95,260.00
Jun 30, 2024 721,489.00
Mar 31, 2024 393,038.00
Dec 31, 2023 356,522.00
Sep 30, 2023 86,374.00
Jun 30, 2023 133,654.00
Mar 31, 2023 102,676.00
Dec 31, 2022 -167.66 Mn
Sep 30, 2022 89.33 Mn